Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company dedicated to finding innovative solutions to improve the lives of patients and caregivers. With a patient-centric approach, we strive to address the challenges faced by individuals managing diseases.

Our team of experienced professionals asks the right questions and identifies issues others may overlook, allowing us to create transformative products. We have a wide range of products and services to offer. Aquestive has five commercially available products marketed by our licensees globally.

Additionally, we collaborate with other pharmaceutical companies to bring new molecules to market by utilizing our proprietary technologies, such as PharmFilm®. Our focus lies in the development of orally administered products that deliver complex molecules, providing patients with novel alternatives to invasive and inconvenient therapies. Leading the way in treating central nervous system diseases and severe allergic reactions, including anaphylaxis, Aquestive is committed to making a meaningful difference in healthcare.

With our dedicated team and strong partnerships, we are revolutionizing drug delivery and enhancing patient outcomes